Positive Antinuclear Antibody (ANA)-Negative Systemic Lupus Erythematosus (SLE) Presenting With Acute Pancreatitis

被引:0
作者
Samanta, Joydeep [1 ]
Mitra, Souveek [2 ]
Sen, Kaushik [3 ]
Saha, Avishek [4 ]
机构
[1] Inst Med Sci & SUM Hosp, Rheumatol, Bhubaneswar, India
[2] Inst Post Grad Med Educ & Res, Hepatol, Kolkata, India
[3] Nilratan Sircar Med Coll, Internal Med, Kolkata, India
[4] Nilratan Sircar Med Coll, Cardiol, Kolkata, India
关键词
systemic lupus erythematosus; acute cutaneous lupus erythematosus; subacute cutaneous lupus erythematosus; acute pancreatitis; ana negative; TESTS;
D O I
10.7759/cureus.23031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is an autoimmune disease with multisystem involvement and most commonly affects women of childbearing age. Most of the patients, if not all, have positive antinuclear antibody (ANA) in their serum. ANA-negative SLE is extremely rare. Here, we present a case of a 15-year-old girl presenting with pancreatitis due to ANA-negative SLE.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus
    Kwon, Oh Chan
    Kim, Yong-Gil
    Park, Jung Hwan
    Park, Min-Chan
    LUPUS, 2020, 29 (07) : 697 - 704
  • [22] Erythropoietic protoporphyria with antinuclear antibody positivity: Avoiding misdiagnosis of systemic lupus erythematosus
    Sonmez, A
    Bulucu, F
    Sener, O
    Serdar, M
    Unal, T
    Caliskaner, Z
    Kocabalkan, F
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 2000, 10 (01) : 47 - 48
  • [23] Longitudinal antinuclear antibody titers in systemic lupus erythematosus and other rheumatic diseases
    Littlejohn, Emily A.
    Kong, Lingxuan
    Wang, Lu
    Somers, Emily C.
    FRONTIERS IN MEDICINE, 2024, 11
  • [24] Clinical features, severity and outcome of acute pancreatitis in systemic lupus erythematosus
    Muhammed, Hafis
    Jain, Avinash
    Irfan, Mohammad
    Charles, Sheba
    Dwivedi, Preksha
    Chavan, Pallavi Pimpale
    Khubchandani, Raju
    Sharma, Amit
    Phatak, Sanat
    Shukla, Anuj N.
    Shah, Ripal
    Subramanian, N.
    Pandya, Sapan C.
    Singh, Yogesh Preet
    Chengappa, K. G.
    Thabah, Molly
    Rajasekhar, Liza
    Shobha, Vineeta
    Negi, V. S.
    Dhir, Varun
    Sharma, Aman
    Misra, Ramnath
    Aggarwal, Amita
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (08) : 1363 - 1371
  • [25] Clinical features, severity and outcome of acute pancreatitis in systemic lupus erythematosus
    Hafis Muhammed
    Avinash Jain
    Mohammad Irfan
    Sheba Charles
    Preksha Dwivedi
    Pallavi Pimpale Chavan
    Raju Khubchandani
    Amit Sharma
    Sanat Phatak
    Anuj N. Shukla
    Ripal Shah
    N. Subramanian
    Sapan C. Pandya
    Yogesh Preet Singh
    K. G. Chengappa
    Molly Thabah
    Liza Rajasekhar
    Vineeta Shobha
    V. S. Negi
    Varun Dhir
    Aman Sharma
    Ramnath Misra
    Amita Aggarwal
    Rheumatology International, 2022, 42 : 1363 - 1371
  • [26] Systemic lupus erythematosus presenting as acute symptomatic hypercalcemia
    Erdozain, JG
    Egurbide, MV
    Ruiz-Irastorza, G
    Ojanguren, J
    Aguirre, C
    LUPUS, 2004, 13 (02) : 132 - 134
  • [27] Antinuclear antibody (ANA)-positive thrombocytopenia: primary, but with a difference
    Marmont, Alberto M.
    BLOOD, 2009, 114 (09) : 2003 - 2004
  • [28] Systemic lupus erythematosus presenting as autoimmune parotitis and pancreatitis - Case Report
    Geraldino, Geise Cristina
    Polizelli, Daniela Vichiato
    Pedroso, Camila Lobo
    de Toledo, Ricardo Acayaba
    Leonardi Bertazzi, Glauce Rejane
    de Toledo, Roberto Acayaba
    Menin, Rita de Cassia
    Funes, Elisete
    ACTA REUMATOLOGICA PORTUGUESA, 2010, 35 (02): : 241 - 243
  • [29] Hydroxychloroquine in systemic lupus erythematosus (SLE)
    Ponticelli, C.
    Moroni, G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 411 - 419
  • [30] Contraception in Systemic Lupus Erythematosus (SLE)
    Faizan Shaukat
    Stephanie Keeling
    Current Treatment Options in Rheumatology, 2019, 5 : 346 - 362